Free Trial Free TrialFree Trial

More results...

Filter by Content types
Market profile databases
Regulatory databases
Regulatory reports
Market reports
Market Snapshots
Infographics
News analysis
Pricing snapshots
Brand price trackers
Flavour trackers
Filter by Geography
Africa
Asia
Australasia
Central America
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • South Africa Committee shows mixed reactions to tobacco control bill…
  • Europe EC answers MEP question over possible conflict of interest…
  • Ukraine Resolution published on restricting minors’ access to e-cig websites…
  • Russia State Duma passes bill to regulate production and distribution…
  • Dominican Republic Health minister urges young people to quit vaping…
  • Spain MEPs call for EU-wide public vaping ban…
  • Spain Pharmacists council wants a ban on e-cig sales by pharmacies…
  • Chile Minister warns against e-cigarette use on World No Tobacco Day…
  • Vietnam National Assembly hears call for total ban on e-cigarettes…
  • New Zealand New rules to tackle youth vaping ‘coming soon’…
  • United States FDA cracks the whip over illegal sales of popular disposables…
  • World WHO calls for ending subsidies for tobacco farming…
View all
News analysis

FDA extends youth anti-smoking campaign to ENDS products

Written by || 9th August 2017 || News analysis || Health and science | Policy and Politics | North America United States

The U.S. Food and Drug Administration (FDA) plans to extend its youth anti-smoking campaign, “The Real Cost”, to e-cigarettes. ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

FDA decision sends the right signals, says a relieved industry
Gottlieb sees ‘an opportunity’ for e-cigs as leader of the FDA
In Congress, deeming reformers welcome FDA’s policy shift